Literature DB >> 9173913

Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury.

D M Ferriero1, D M Holtzman, S M Black, R A Sheldon.   

Abstract

We hypothesized that elimination of neuronal nitric oxide synthase (nNOS) by targeted disruption of the nNOS gene would result in amelioration of damage seen after hypoxia-ischemia in the developing brain since nitric oxide (NO) has been implicated in glutamate-mediated neurotoxicity after ischemia. Both wildtype and nNOS-deficient pups were subjected to focal ischemia followed by 1.5 h of hypoxia at Postnatal Day 7. Seven days later, brains of surviving animals were analyzed for damage. The nNOS-deficient pups (n = 17) had less histopathologic evidence of injury in both the hippocampus (P = 0.008) and the cortex (P = 0.0008) than the wildtype (n = 30) mice. When injured, the nNOS-deficient mice had damage that was limited to the hippocampus. These results support a role for neuronally produced NO in injury after perinatal hypoxia-ischemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9173913     DOI: 10.1006/nbdi.1996.0006

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  42 in total

Review 1.  Imaging selective vulnerability in the developing nervous system.

Authors:  Donna M Ferriero; Steven P Miller
Journal:  J Anat       Date:  2010-10       Impact factor: 2.610

2.  Involvement of neuronal nitric oxide synthase in ongoing fetal brain injury following near-term rabbit hypoxia-ischemia.

Authors:  Suma Rao; Zhenlang Lin; Alexander Drobyshevsky; Lina Chen; Xinhai Ji; Haitao Ji; Yirong Yang; Lei Yu; Matthew Derrick; Richard B Silverman; Sidhartha Tan
Journal:  Dev Neurosci       Date:  2011-07-08       Impact factor: 2.984

3.  Perinatal hypoxia/ischemia damages and depletes progenitors from the mouse subventricular zone.

Authors:  Christine Y Brazel; Robert T Rosti; Sheri Boyce; Raymond P Rothstein; Steven W Levison
Journal:  Dev Neurosci       Date:  2004 Mar-Aug       Impact factor: 2.984

4.  Augmentation of nitric oxide, superoxide, and peroxynitrite production during cerebral ischemia and reperfusion in the rat.

Authors:  L J Forman; P Liu; R G Nagele; K Yin; P Y Wong
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

5.  Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy.

Authors:  Haitao Ji; Sidhartha Tan; Jotaro Igarashi; Huiying Li; Matthew Derrick; Pavel Martásek; Linda J Roman; Jeannette Vásquez-Vivar; Thomas L Poulos; Richard B Silverman
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422

Review 6.  Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury.

Authors:  Xing-miao Chen; Han-sen Chen; Ming-jing Xu; Jian-gang Shen
Journal:  Acta Pharmacol Sin       Date:  2012-07-30       Impact factor: 6.150

7.  Sex-dependent mitochondrial respiratory impairment and oxidative stress in a rat model of neonatal hypoxic-ischemic encephalopathy.

Authors:  Tyler G Demarest; Rosemary A Schuh; Jaylyn Waddell; Mary C McKenna; Gary Fiskum
Journal:  J Neurochem       Date:  2016-05-06       Impact factor: 5.372

8.  Rapid NMDA receptor phosphorylation and oxidative stress precede striatal neurodegeneration after hypoxic ischemia in newborn piglets and are attenuated with hypothermia.

Authors:  Dawn Mueller-Burke; Raymond C Koehler; Lee J Martin
Journal:  Int J Dev Neurosci       Date:  2007-09-08       Impact factor: 2.457

9.  Synthesis and enzymatic evaluation of 2- and 4-aminothiazole-based inhibitors of neuronal nitric oxide synthase.

Authors:  Graham R Lawton; Haitao Ji; Pavel Martásek; Linda J Roman; Richard B Silverman
Journal:  Beilstein J Org Chem       Date:  2009-06-04       Impact factor: 2.883

Review 10.  Hypoxic-ischemic encephalopathy in the term infant.

Authors:  Ali Fatemi; Mary Ann Wilson; Michael V Johnston
Journal:  Clin Perinatol       Date:  2009-12       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.